#3468
Novel morphological tools in predicting pancreatic neuroendocrine tumors (Pan-Net) clinical outcome
Introduction:
Pancreatic Neuroendocrine Tumor (Pan-NET) clinical outcome shows a high variability among patients within the same World Health Organization (WHO) category. To date, there is a lack of markers to predict recurrence after resection, which makes it difficult to identify patients with higher risk of progression.
Conference:
Presenting Author:
Authors:
Lagano V,
Sabella G,
Cattaneo L,
Grillo F,
Mangogna A,
Keywords:
Pancreas,
parenchymal infiltration,
tumor deposits,
#2841
Novelties in Primary and Metastatic GEP-NENs Clinical Outcome Investigation
Introduction:
Gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NENs) WHO classification, using strict cut-offs, should reflect their biological features. In real world, strict cut-offs not adequately segregate prognostic groups, in particular on metastasis (M).
Conference:
17th Annual ENETSConcerence (2020)
Presenting Author:
Milione M
Authors:
Kankava K,
Maisonneuve P,
Mangogna A,
Centonze G,
Cattaneo L,
Keywords:
Gastro-entero-pancreatic neuroendocrine neoplasms,
primary tumor,
metastasis,
Ki-67,
mitoses,
tumor deposits,
clinical outcomes,